Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Oxtellar XR for the Treatment of Partial Seizures

Drug Name (Brand / Generic)

Oxtellar XR / oxcarbazepine / SPN-804

Developed By

Supernus Pharmaceuticals

Therapy Class

Anti-epileptic drug

Current Indication

Partial seizures

Market Sector

CNS

Development Status

Approved in the US
Expand

Go Top